Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    "21-hydroxylase deficiency"
Show Display Options
Rank Status Study
21 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
22 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
23 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
Intervention:
24 Recruiting Decision Support for Parents Receiving Information About Child's Rare Disease
Conditions: Disorder of Sex Development;   Intersex Conditions;   Congenital Adrenal Hyperplasia;   Hypospadias
Intervention: Behavioral: Decision Support Tool
25 Completed Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
Conditions: Adrenal Hyperplasia, Congenital;   Congenital Hypothyroidism;   Cystic Fibrosis
Intervention:
26 Withdrawn Gene Polymorphisms Influencing Steroid Synthesis and Action
Conditions: Disorders of Sex Development;   Congenital Adrenal Hyperplasia;   Congenital Adrenal Hypoplasia;   Adrenal Insufficiency;   Mineralocorticoid Deficiency;   Intersex
Intervention:
27 Unknown  Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism;   Congenital Adrenal Hyperplasia;   Hypertension
Intervention: Procedure: blood drawing
28 Completed The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women
Conditions: Polycystic Ovary Syndrome;   Anovulation;   Oligoovulation;   Infertility;   Hyperandrogenism
Interventions: Drug: Metformin;   Drug: Clomiphene citrate;   Drug: Placebo
29 Active, not recruiting Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
Condition: Polycystic Ovary Syndrome
Intervention: Drug: 3 mg DRSP/20 μg EE
30 Unknown  Meal Timing on Glucose and Hyperandrogenism in PCOS Women
Condition: Polycystic Ovary Syndrome (PCOS) Women
Interventions: Behavioral: Placebo Comparator: Lifestyle counseling Dinner Diet ARM 2;   Other: Active Comparator: Lifestyle counseling ARM 1
31 Unknown  Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
Conditions: Amenorrhea;   Dysmenorrhea;   Menstruation Disturbances;   Hyperandrogenism
Intervention: Drug: Ethinyl Estradiol + Cyproterone acetate
32 Completed Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
Conditions: Hyperandrogenism,;   Polycystic Ovary Syndrome,;   Metabolic Syndrome,;   Insulin Resistance,;   Cardiovascular Disease.
Intervention:
33 Completed Effects of Androgen Administration on Inflammation in Normal Women
Condition: Hyperandrogenism
Interventions: Dietary Supplement: Dehydroepiandrosterone (DHEA);   Other: Placebo
34 Completed Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Orlistat/Meal Replacement/Lifestyle Modification;   Drug: Loestrin 1/20;   Drug: Combination of treatments
35 Recruiting Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Rosiglitazone;   Drug: Acarbose
36 Completed Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome
Conditions: Hyperandrogenism;   Insulin Resistance
Intervention: Other: Dietary  intervention
37 Completed Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Condition: Hyperandrogenism
Interventions: Drug: leuprolide;   Drug: Ethinyl estradiol/norethindrone
38 Completed Obesity and Clinical Presentation of Hyperandrogenism
Condition: Polycystic Ovary Syndrome
Intervention:
39 Recruiting 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism
Condition: Primary Hyperaldosteronism
Intervention: Procedure: 11C-Metomidate Positron Emission Tomography
40 Active, not recruiting SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.
Condition: Hyperaldosteronism
Intervention: Other: Ct-scan or adrenal vein sampling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years